New insights into the pathology of inherited cardiomyopathy

Cardiomyopathies are defined as diseases of the myocardium, which cause cardiac dysfunction with heart failure, arrhythmia, and sudden death. Cardiomyopathies represent a major cause of morbidity and mortality in both children and adults and are a frequent indication for cardiac transplantation. In 1995, the World Health Organization (WHO)/International Society and Federation of Cardiology (ISFC) task force recommended that the cardiomyopathies be classified into two main groups: specific cardiomyopathies, and primary cardiomyopathies.1 The specific cardiomyopathies include heart muscle disease associated with myocarditis, specific cardiac disease or general systemic disease. In contrast, the primary cardiomyopathies are diseases intrinsic to the myocardium itself and are classified pathophysiologically. This group includes dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and unclassified cardiomyopathy. Idiopathic dilated cardiomyopathy (DCM) is the most common cause of congestive heart failure in the young with an estimated prevalence of at least 36.5 per 100 000 persons in the USA.w1 DCM is characterised by an increase in myocardial mass and a reduction in ventricular wall thickness. The heart assumes a globular shape and there is pronounced ventricular chamber dilatation, diffuse endocardial thickening, and atrial enlargement often with thrombi in the appendages. The histological changes associated with DCM are frequently non-specific and not all features may be present. These include the constellation of myocyte attenuation, interstitial fibrosis, myocyte nuclear hypertrophy, and pleomorphism. There is often an increase in interstitial T lymphocytes as well as focal accumulations of macrophages associated with individual myocyte death. Frequently there is extensive myofibrillary loss, imparting an empty or vacuolated appearance to myocytes. Although the aetiology of these cases is largely unknown, up to 35% of individuals with idiopathic DCM have familial disease.w2 This has been shown by detailed pedigree analyses of relatives of index patients with DCM coupled …

[1]  D TEARE,et al.  ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.

[2]  C. Kawai,et al.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. , 1980, British heart journal.

[3]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[4]  J. Berden,et al.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes , 1983, Journal of the Neurological Sciences.

[5]  R. Kyle,et al.  Clinical significance of histopathologic patterns of cardiac amyloidosis. , 1984, Mayo Clinic proceedings.

[6]  E. Olsen,et al.  Pathology of hypertrophic cardiomyopathy. , 1986, Postgraduate medical journal.

[7]  J. Child,et al.  The restrictive cardiomyopathies. , 1988, Cardiology clinics.

[8]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[9]  J. Perloff,et al.  Isolated noncompaction of left ventricular myocardium. A study of eight cases. , 1990, Circulation.

[10]  F. Pelliccia,et al.  Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. , 1992, Human pathology.

[11]  B. Wallin,et al.  Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis , 1993, The Lancet.

[12]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[13]  W. Roberts,et al.  Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. , 1995, The American journal of cardiology.

[14]  W. McKenna,et al.  Hypertrophic cardiomyopathy — pathology and pathogenesis , 1995, Histopathology.

[15]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[16]  E. Maestrini,et al.  A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.

[17]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[18]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[19]  E. Topol Textbook of Cardiovascular Medicine , 1997 .

[20]  M. Ritter,et al.  Isolated noncompaction of the myocardium in adults. , 1997, Mayo Clinic proceedings.

[21]  E. Haan,et al.  The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. , 1997, American journal of human genetics.

[22]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[23]  R. Virmani,et al.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? , 1998, Circulation.

[24]  A. Angelini,et al.  In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. , 1998, The American journal of pathology.

[25]  J. Liepnieks,et al.  Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. , 1999, The American journal of pathology.

[26]  Neil E. Bowles,et al.  The “Final Common Pathway” Hypothesis and Inherited Cardiovascular Disease The Role of Cytoskeletal Proteins in Dilated Cardiomyopathy , 2000, Herz.

[27]  M. Aschermann,et al.  New insights in cardiac structural changes in patients with Fabry's disease. , 2000, American heart journal.

[28]  A. Angelini,et al.  No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy , 2000, Journal of clinical pathology.

[29]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[30]  Robert H. Anderson,et al.  Developmental patterning of the myocardium , 2000, The Anatomical record.

[31]  E. Wigle,et al.  The diagnosis of hypertrophic cardiomyopathy , 2001, Heart.

[32]  Andy Jj Aetiology of endomyocardial fibrosis (EMF). , 2001 .

[33]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[34]  H. Yagi,et al.  A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92). , 2001, Human pathology.

[35]  B. Marino,et al.  Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns. , 2001, Human pathology.

[36]  J. Andy Aetiology of endomyocardial fibrosis (EMF). , 2001, West African journal of medicine.

[37]  L. Mestroni,et al.  Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[38]  A. Marian,et al.  Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. , 2001, Minerva medica.

[39]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[40]  B. Maron Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[41]  J. Towbin,et al.  The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[42]  J. Towbin,et al.  The failing heart , 2002, Nature.

[43]  P. Elliott,et al.  Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy , 2002, Circulation.

[44]  P. Elliott,et al.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.

[45]  F. Marcus,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2000, Circulation.

[46]  J. Liepnieks,et al.  Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. , 2003, Kidney international.

[47]  K. Sletten,et al.  Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.